ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Lombardi Recruits Adams-Campbell.

October 3, 2008

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003